![Henri Theunissen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henri Theunissen
Amministratore Delegato presso BioMedbooster BV
Posizioni attive di Henri Theunissen
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioMedbooster BV
![]() BioMedbooster BV Miscellaneous Commercial ServicesCommercial Services BioMedbooster BV provides valorization services. It supports businesses in translating their inventions or ideas into products ready for marketing. The company builds bridges between scientific research and industry, especially in life sciences and biomedical technologies. The firm offers evaluation of commercial potential of the invention, market analysis, managing the patenting process, business plan development, financial support for patent application in selected cases, business development financing, finding seed capital, monitoring contracts and payments, strong connections in scientific, industrial and financial communities, finding licensees and monitoring patent infringement. BioMedbooster was founded in 2005 and is headquartered in Maastricht, the Netherlands. | Amministratore Delegato | 01/11/2009 | - |
Storia della carriera di Henri Theunissen
Precedenti posizioni note di Henri Theunissen
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACS Biomarker BV
![]() ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Direttore/Membro del Consiglio | - | - |
Diosynth RTP, Inc.
![]() Diosynth RTP, Inc. BiotechnologyHealth Technology Diosynth RTP, Inc. provides current good manufacturing practices and pharmaceutical products. Its products include monoclonal antibodies, cancer vaccines, fusion proteins, cancer vaccines, and anti coagulants. The company was founded on February 28, 1995 and is headquartered in Morrisville, NC | Corporate Officer/Principal | - | - |
Nobilon International BV | Corporate Officer/Principal | - | - |
Organon International BV | Corporate Officer/Principal | - | - |
Formazione di Henri Theunissen
University of Amsterdam | Doctorate Degree |
Radboud University Nijmegen | Undergraduate Degree |
Statistiche
Distribuzione geografica
Paesi Bassi | 7 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Diosynth RTP, Inc.
![]() Diosynth RTP, Inc. BiotechnologyHealth Technology Diosynth RTP, Inc. provides current good manufacturing practices and pharmaceutical products. Its products include monoclonal antibodies, cancer vaccines, fusion proteins, cancer vaccines, and anti coagulants. The company was founded on February 28, 1995 and is headquartered in Morrisville, NC | Health Technology |
BioMedbooster BV
![]() BioMedbooster BV Miscellaneous Commercial ServicesCommercial Services BioMedbooster BV provides valorization services. It supports businesses in translating their inventions or ideas into products ready for marketing. The company builds bridges between scientific research and industry, especially in life sciences and biomedical technologies. The firm offers evaluation of commercial potential of the invention, market analysis, managing the patenting process, business plan development, financial support for patent application in selected cases, business development financing, finding seed capital, monitoring contracts and payments, strong connections in scientific, industrial and financial communities, finding licensees and monitoring patent infringement. BioMedbooster was founded in 2005 and is headquartered in Maastricht, the Netherlands. | Commercial Services |
Organon International BV | |
ACS Biomarker BV
![]() ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Health Technology |
Nobilon International BV |
- Borsa valori
- Insiders
- Henri Theunissen
- Esperienza